Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Joint problems arising from lack of repair mechanisms: can cannabinoids help?

Malek N, Starowicz K.

Br J Pharmacol. 2018 Mar 25. doi: 10.1111/bph.14204. [Epub ahead of print] Review.

PMID:
29574720
2.

Molecular Understanding of the Activation of CB1 and Blockade of TRPV1 Receptors: Implications for Novel Treatment Strategies in Osteoarthritis.

Mlost J, Kostrzewa M, Malek N, Starowicz K.

Int J Mol Sci. 2018 Jan 24;19(2). pii: E342. doi: 10.3390/ijms19020342.

3.

Cell-type-specific gene expression patterns in the knee cartilage in an osteoarthritis rat model.

Korostynski M, Malek N, Piechota M, Starowicz K.

Funct Integr Genomics. 2018 Jan;18(1):79-87. doi: 10.1007/s10142-017-0576-6. Epub 2017 Nov 13.

4.

Expression of matrix metalloproteinases and components of the endocannabinoid system in the knee joint are associated with biphasic pain progression in a rat model of osteoarthritis.

Pajak A, Kostrzewa M, Malek N, Korostynski M, Starowicz K.

J Pain Res. 2017 Aug 21;10:1973-1989. doi: 10.2147/JPR.S132682. eCollection 2017.

5.

Cannabinoids and Pain: Sites and Mechanisms of Action.

Starowicz K, Finn DP.

Adv Pharmacol. 2017;80:437-475. doi: 10.1016/bs.apha.2017.05.003. Epub 2017 Jun 20. Review.

PMID:
28826543
6.

Blood Transcriptional Signatures for Disease Progression in a Rat Model of Osteoarthritis.

Korostyński M, Małek N, Piechota M, Starowicz K.

Int J Genomics. 2017;2017:1746426. doi: 10.1155/2017/1746426. Epub 2017 Jul 3.

7.

Allodynia Lowering Induced by Cannabinoids and Endocannabinoids (ALICE).

Luongo L, Starowicz K, Maione S, Di Marzo V.

Pharmacol Res. 2017 May;119:272-277. doi: 10.1016/j.phrs.2017.02.019. Epub 2017 Feb 22. Review.

PMID:
28237514
8.

Polycomb complexes PRC1 and their function in hematopoiesis.

Vidal M, Starowicz K.

Exp Hematol. 2017 Apr;48:12-31. doi: 10.1016/j.exphem.2016.12.006. Epub 2017 Jan 10. Review.

9.

Dual-Acting Compounds Targeting Endocannabinoid and Endovanilloid Systems-A Novel Treatment Option for Chronic Pain Management.

Malek N, Starowicz K.

Front Pharmacol. 2016 Aug 17;7:257. doi: 10.3389/fphar.2016.00257. eCollection 2016. Review.

10.

The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain.

Malek N, Kostrzewa M, Makuch W, Pajak A, Kucharczyk M, Piscitelli F, Przewlocka B, Di Marzo V, Starowicz K.

Pharmacol Res. 2016 Sep;111:251-263. doi: 10.1016/j.phrs.2016.06.012. Epub 2016 Jun 17.

PMID:
27326920
11.

Role of Polycomb RYBP in Maintaining the B-1-to-B-2 B-Cell Lineage Switch in Adult Hematopoiesis.

Calés C, Pavón L, Starowicz K, Pérez C, Bravo M, Ikawa T, Koseki H, Vidal M.

Mol Cell Biol. 2015 Dec 28;36(6):900-12. doi: 10.1128/MCB.00869-15.

12.

Anandamide mediates cognitive judgement bias in rats.

Kregiel J, Malek N, Popik P, Starowicz K, Rygula R.

Neuropharmacology. 2016 Feb;101:146-53. doi: 10.1016/j.neuropharm.2015.09.009. Epub 2015 Sep 9.

PMID:
26363193
13.

Polycomb RING1A- and RING1B-dependent histone H2A monoubiquitylation at pericentromeric regions promotes S-phase progression.

Bravo M, Nicolini F, Starowicz K, Barroso S, Calés C, Aguilera A, Vidal M.

J Cell Sci. 2015 Oct 1;128(19):3660-71. doi: 10.1242/jcs.173021. Epub 2015 Aug 13.

14.

Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures.

Malek N, Popiolek-Barczyk K, Mika J, Przewlocka B, Starowicz K.

Neural Plast. 2015;2015:130639. doi: 10.1155/2015/130639. Epub 2015 May 18.

15.

Chronic pain: new insights in molecular and cellular mechanisms.

Luongo L, Malcangio M, Salvemini D, Starowicz K.

Biomed Res Int. 2015;2015:676725. doi: 10.1155/2015/676725. Epub 2015 Mar 23. No abstract available.

16.

A multi-target approach for pain treatment: dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis.

Malek N, Mrugala M, Makuch W, Kolosowska N, Przewlocka B, Binkowski M, Czaja M, Morera E, Di Marzo V, Starowicz K.

Pain. 2015 May;156(5):890-903. doi: 10.1097/j.pain.0000000000000132. Erratum in: Pain. 2015 Jul;156(7):1370.

PMID:
25719612
17.

The importance of TRPV1-sensitisation factors for the development of neuropathic pain.

Malek N, Pajak A, Kolosowska N, Kucharczyk M, Starowicz K.

Mol Cell Neurosci. 2015 Mar;65:1-10. doi: 10.1016/j.mcn.2015.02.001. Epub 2015 Feb 4.

PMID:
25662734
18.

Alterations in the anandamide metabolism in the development of neuropathic pain.

Malek N, Kucharczyk M, Starowicz K.

Biomed Res Int. 2014;2014:686908. doi: 10.1155/2014/686908. Epub 2014 Sep 2.

19.

Delta-opioid receptor analgesia is independent of microglial activation in a rat model of neuropathic pain.

Mika J, Popiolek-Barczyk K, Rojewska E, Makuch W, Starowicz K, Przewlocka B.

PLoS One. 2014 Aug 8;9(8):e104420. doi: 10.1371/journal.pone.0104420. eCollection 2014.

20.

Heme oxygenase-1 is required for angiogenic function of bone marrow-derived progenitor cells: role in therapeutic revascularization.

Grochot-Przeczek A, Kotlinowski J, Kozakowska M, Starowicz K, Jagodzinska J, Stachurska A, Volger OL, Bukowska-Strakova K, Florczyk U, Tertil M, Jazwa A, Szade K, Stepniewski J, Loboda A, Horrevoets AJ, Dulak J, Jozkowicz A.

Antioxid Redox Signal. 2014 Apr 10;20(11):1677-92. doi: 10.1089/ars.2013.5426. Epub 2014 Feb 28.

21.

Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism.

Starowicz K, Makuch W, Korostynski M, Malek N, Slezak M, Zychowska M, Petrosino S, De Petrocellis L, Cristino L, Przewlocka B, Di Marzo V.

PLoS One. 2013;8(4):e60040. doi: 10.1371/journal.pone.0060040. Epub 2013 Apr 3.

22.

Non-psychotropic analgesic drugs from the endocannabinoid system: "magic bullet" or "multiple-target" strategies?

Starowicz K, Di Marzo V.

Eur J Pharmacol. 2013 Sep 15;716(1-3):41-53. doi: 10.1016/j.ejphar.2013.01.075. Epub 2013 Mar 13. Review.

PMID:
23500197
23.

Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system.

Starowicz K, Przewlocka B.

Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3286-99. doi: 10.1098/rstb.2011.0392. Review.

24.

A re-evaluation of 9-HODE activity at TRPV1 channels in comparison with anandamide: enantioselectivity and effects at other TRP channels and in sensory neurons.

De Petrocellis L, Schiano Moriello A, Imperatore R, Cristino L, Starowicz K, Di Marzo V.

Br J Pharmacol. 2012 Dec;167(8):1643-51. doi: 10.1111/j.1476-5381.2012.02122.x.

25.

Spinal anandamide produces analgesia in neuropathic rats: possible CB(1)- and TRPV1-mediated mechanisms.

Starowicz K, Makuch W, Osikowicz M, Piscitelli F, Petrosino S, Di Marzo V, Przewlocka B.

Neuropharmacology. 2012 Mar;62(4):1746-55. doi: 10.1016/j.neuropharm.2011.11.021. Epub 2011 Dec 8.

PMID:
22178705
26.

Agonist-dependent attenuation of mu-opioid receptor-mediated G-protein activation in the dorsal root ganglia of neuropathic rats.

Obara I, Gunduz Cinar O, Starowicz K, Benyhe S, Borsodi A, Przewlocka B.

J Neural Transm (Vienna). 2010 Apr;117(4):421-9. doi: 10.1007/s00702-010-0382-y. Epub 2010 Mar 6.

PMID:
20213428
27.

Peripheral antinociceptive effects of MC4 receptor antagonists in a rat model of neuropathic pain - a biochemical and behavioral study.

Starowicz K, Mousa SA, Obara I, Chocyk A, Przewłocki R, Wedzony K, Machelska H, Przewłocka B.

Pharmacol Rep. 2009 Nov-Dec;61(6):1086-95.

28.

TRPV1 channels control synaptic plasticity in the developing superior colliculus.

Maione S, Cristino L, Migliozzi AL, Georgiou AL, Starowicz K, Salt TE, Di Marzo V.

J Physiol. 2009 Jun 1;587(Pt 11):2521-35. doi: 10.1113/jphysiol.2009.171900. Epub 2009 Apr 30.

29.

Functional interaction between TRPV1 and mu-opioid receptors in the descending antinociceptive pathway activates glutamate transmission and induces analgesia.

Maione S, Starowicz K, Cristino L, Guida F, Palazzo E, Luongo L, Rossi F, Marabese I, de Novellis V, Di Marzo V.

J Neurophysiol. 2009 May;101(5):2411-22. doi: 10.1152/jn.91225.2008. Epub 2009 Mar 18.

30.

The analgesic effect of N-arachidonoyl-serotonin, a FAAH inhibitor and TRPV1 receptor antagonist, associated with changes in rostral ventromedial medulla and locus coeruleus cell activity in rats.

de Novellis V, Palazzo E, Rossi F, De Petrocellis L, Petrosino S, Guida F, Luongo L, Migliozzi A, Cristino L, Marabese I, Starowicz K, Di Marzo V, Maione S; Endocannabinoid Research Group.

Neuropharmacology. 2008 Dec;55(7):1105-13. doi: 10.1016/j.neuropharm.2008.06.023. Epub 2008 Jun 20.

PMID:
18616956
31.

Immunohistochemical localization of anabolic and catabolic enzymes for anandamide and other putative endovanilloids in the hippocampus and cerebellar cortex of the mouse brain.

Cristino L, Starowicz K, De Petrocellis L, Morishita J, Ueda N, Guglielmotti V, Di Marzo V.

Neuroscience. 2008 Feb 19;151(4):955-68. doi: 10.1016/j.neuroscience.2007.11.047. Epub 2007 Dec 8.

PMID:
18248904
32.

Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet.

Starowicz KM, Cristino L, Matias I, Capasso R, Racioppi A, Izzo AA, Di Marzo V.

Obesity (Silver Spring). 2008 Mar;16(3):553-65. doi: 10.1038/oby.2007.106. Epub 2008 Jan 17.

33.

TRPV1 receptors in the central nervous system: potential for previously unforeseen therapeutic applications.

Starowicz K, Cristino L, Di Marzo V.

Curr Pharm Des. 2008;14(1):42-54. Review.

PMID:
18220817
34.

New Potential Therapies from Vanilloid Transient Receptor Cation (TRPV) Channels.

Di Marzo V, Starowicz K.

Curr Pharm Des. 2008;14(1):1. No abstract available.

PMID:
18220813
35.

Tonic endovanilloid facilitation of glutamate release in brainstem descending antinociceptive pathways.

Starowicz K, Maione S, Cristino L, Palazzo E, Marabese I, Rossi F, de Novellis V, Di Marzo V.

J Neurosci. 2007 Dec 12;27(50):13739-49.

36.

Mechanisms for the coupling of cannabinoid receptors to intracellular calcium mobilization in rat insulinoma beta-cells.

De Petrocellis L, Marini P, Matias I, Moriello AS, Starowicz K, Cristino L, Nigam S, Di Marzo V.

Exp Cell Res. 2007 Aug 15;313(14):2993-3004. Epub 2007 May 18.

PMID:
17585904
37.

Attenuation of allergic contact dermatitis through the endocannabinoid system.

Karsak M, Gaffal E, Date R, Wang-Eckhardt L, Rehnelt J, Petrosino S, Starowicz K, Steuder R, Schlicker E, Cravatt B, Mechoulam R, Buettner R, Werner S, Di Marzo V, Tüting T, Zimmer A.

Science. 2007 Jun 8;316(5830):1494-7.

38.

Periaqueductal gray metabotropic glutamate receptor subtype 7 and 8 mediate opposite effects on amino acid release, rostral ventromedial medulla cell activities, and thermal nociception.

Marabese I, Rossi F, Palazzo E, de Novellis V, Starowicz K, Cristino L, Vita D, Gatta L, Guida F, Di Marzo V, Rossi F, Maione S.

J Neurophysiol. 2007 Jul;98(1):43-53. Epub 2007 May 16.

39.

Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret.

Sharkey KA, Cristino L, Oland LD, Van Sickle MD, Starowicz K, Pittman QJ, Guglielmotti V, Davison JS, Di Marzo V.

Eur J Neurosci. 2007 May;25(9):2773-82. Epub 2007 Apr 25.

PMID:
17459108
40.

Regulation of transient receptor potential channels of melastatin type 8 (TRPM8): effect of cAMP, cannabinoid CB(1) receptors and endovanilloids.

De Petrocellis L, Starowicz K, Moriello AS, Vivese M, Orlando P, Di Marzo V.

Exp Cell Res. 2007 May 15;313(9):1911-20. Epub 2007 Jan 18.

PMID:
17428469
41.

Biochemistry and pharmacology of endovanilloids.

Starowicz K, Nigam S, Di Marzo V.

Pharmacol Ther. 2007 Apr;114(1):13-33. Epub 2007 Feb 2. Review.

PMID:
17349697
42.

Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma.

Ligresti A, Moriello AS, Starowicz K, Matias I, Pisanti S, De Petrocellis L, Laezza C, Portella G, Bifulco M, Di Marzo V.

J Pharmacol Exp Ther. 2006 Sep;318(3):1375-87. Epub 2006 May 25.

43.

Inhibition of morphine tolerance by spinal melanocortin receptor blockade.

Starowicz K, Obara I, Przewłocki R, Przewlocka B.

Pain. 2005 Oct;117(3):401-11.

PMID:
16153779
44.

Morphine-induced changes in the activity of proopiomelanocortin and prodynorphin systems in zymosan-induced peritonitis in mice.

Chadzinska M, Starowicz K, Scislowska-Czarnecka A, Bilecki W, Pierzchala-Koziec K, Przewlocki R, Przewlocka B, Plytycz B.

Immunol Lett. 2005 Nov 15;101(2):185-92. Epub 2005 Jun 13.

PMID:
15979727
45.

Melanocortin 4 receptor is expressed in the dorsal root ganglions and down-regulated in neuropathic rats.

Starowicz K, Bilecki W, Sieja A, Przewlocka B, Przewlocki R.

Neurosci Lett. 2004 Mar 25;358(2):79-82.

PMID:
15026153
46.

The effect of morphine on MC4 and CRF receptor mRNAs in the rat amygdala and attenuation of tolerance after their blockade.

Starowicz K, Sieja A, Bilecki W, Obara I, Przewlocka B.

Brain Res. 2003 Nov 14;990(1-2):113-9.

PMID:
14568335
47.

The role of melanocortins and their receptors in inflammatory processes, nerve regeneration and nociception.

Starowicz K, Przewłocka B.

Life Sci. 2003 Jul 4;73(7):823-47. Review.

PMID:
12798410
48.

Modulation of melanocortin-induced changes in spinal nociception by mu-opioid receptor agonist and antagonist in neuropathic rats.

Starowicz K, Przewlocki R, Gispen WH, Przewlocka B.

Neuroreport. 2002 Dec 20;13(18):2447-52.

PMID:
12499847
49.

Knockdown of spinal opioid receptors by antisense targeting beta-arrestin reduces morphine tolerance and allodynia in rat.

Przewlocka B, Sieja A, Starowicz K, Maj M, Bilecki W, Przewlocki R.

Neurosci Lett. 2002 Jun 7;325(2):107-10.

PMID:
12044633

Supplemental Content

Loading ...
Support Center